Page last updated: 2024-10-30

memantine and Amyloid Angiopathy, Cerebral

memantine has been researched along with Amyloid Angiopathy, Cerebral in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Sporadic cerebral amyloid angiopathy (CAA) is characterized by cerebrovascular amyloid beta (Aβ) deposits and causes cerebral hemorrhages and dementia in elderly people."5.51Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression. ( Ando, Y; Inoue, Y; Masuda, T; Misumi, Y; Ueda, M; Yamashita, T, 2019)
"Sporadic cerebral amyloid angiopathy (CAA) is characterized by cerebrovascular amyloid beta (Aβ) deposits and causes cerebral hemorrhages and dementia in elderly people."1.51Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression. ( Ando, Y; Inoue, Y; Masuda, T; Misumi, Y; Ueda, M; Yamashita, T, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, Y1
Ueda, M1
Masuda, T1
Misumi, Y1
Yamashita, T1
Ando, Y1

Other Studies

1 other study available for memantine and Amyloid Angiopathy, Cerebral

ArticleYear
Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression.
    Molecular neurobiology, 2019, Volume: 56, Issue:12

    Topics: Amyloid beta-Peptides; Animals; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Insulysin; Maze

2019